Sydney VC one VenturesOnes has pledged $15 million as a cornerstone investment towards a $25 million Series B raise for life sciences startup ImmVirX. The biotech startup is developing cancer treatments using oncolytic viral immunotherapies (viruses that infect and destroy cancer cells without damaging normal cells). The remaining $10 million in the Series offered to… Read more »
The federal government is seeking feedback on mitigating any potential risks from the use of artificial intelligence technologies (AI) and how to build a safe framework for its use amid growing global concerns that seeing machine learning as potentially an existential threat to humanity. Science and industry minister Ed Husic released two discussion papers on… Read more »
ASX-listed jobs marketplace Airtasker will have its first female board leader with Cass O’Connor stepping into the chair role next month as James Spenceley departs after eight years. Spenceley, the founder of telco Vocus, is a prolific VC investor and North Sydney councillor and more recently founded humanitarian organisation Aus Ukraine Aid, was a seed… Read more »
Biotech incubator CUREator tips $12 million into 19 startups tackling global health
Veteran tech director Cass O’Connor to chair Airtasker as James Spencely steps down to focus on humanitarian work
Agtech accelerator Sparklabs Cultiv8 is backing 10 cleantech startups in a new program
Queensland sustainable packaging startup Earthodic bags $1.85 million pre-Seed round
Daily startup news and insights, delivered to your inbox.
Business strategy
Plenty of entrepreneurs have grand plans for the launch of their business, but too few think about an exit strategy before they begin. This is a fatal mistake. With 90% of startups doomed to failure, founders can’t afford to overlook this most important element to their business’ long-term viability. An exit strategy will not only… Read more »
Funding
Sydney VC one VenturesOnes has pledged $15 million as a cornerstone investment towards a $25 million Series B raise for life sciences startup ImmVirX. The biotech startup is developing cancer treatments using oncolytic viral immunotherapies (viruses that infect and destroy cancer cells without damaging normal cells). The remaining $10 million in the Series offered to… Read more »
Antler Australia
Early stage investment company Antler Australia recently backed a new cohort of startups as part of its ongoing program to build great local tech companies. Startup Daily is sharing the details of each venture in the “Antler Investor Memos” series, which is designed to give you a quick, sharp understanding of the startups and people… Read more »
Daily startup news and insights, delivered to your inbox.
We'll sometimes send messages from our partners. You can opt-out anytime.
